• New CAR T-cell Production Method May Offer Faster, More Targeted Therapies, Study Reports
  • Age Alone Should Not Exclude Lymphoma Patients From Stem Cell Transplants, Researchers Argue
  • FDA Clears Voruciclib for Phase 1 Trial as Potential Treatment for Certain B-cell Malignancies
  • LLS Receives $5M to Support Research Programs in Mantle Cell Lymphoma
  • Breast Implants Associated with Small Increased Risk of Anaplastic Large-cell Lymphoma
  • FDA Cites Lack of Data About Blood Cancer Medications in Older People
  • Leukemia & Lymphoma Society Launches Navigating Cancer’s Network of Support
  • Cellectar Seeks FDA’s OK to Advance CLR 131 into Trials for Rare Pediatric Cancers
  • Atara Starts Two Phase 3 Trials of Treatment for Lymphoma That Arises from a Transplant
  • Survivor’s Guilt After Overcoming Cancer
  • FDA to Review Adcetris, Chemo Combo as First-line Treatment for Advanced Hodgkin’s Lymphoma
  • Verastem to Seek FDA Approval for Duvelisib to Treat SLL and CLL After Consistently Positive Trial Results